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a  b  s  t r  a  c  t
Non-steroidal  anti-inflammatory  drugs  (NSAIDs)  are  commonly  prescribed  by  veterinary  surgeons  for  the
treatment  of canine  osteoarthritis,  and  affected  dogs  may  receive  these  drugs  for  long periods  of  time.
Whilst  short  term  administration  of  NSAIDs  to dogs  is linked  to adverse  events  such  as  gastrointestinal
haemorrhage  and  renal  injury,  reports  of  adverse  events  associated  with  their  long-term  administration
are  limited  in the  veterinary  literature.  This  study  aimed  to investigate  the  attitudes  towards  the  long
term  use  of NSAIDs  for  canine  osteoarthritis  held  by  three  groups  who  manage  osteoarthritic  dogs  in the
United  Kingdom:  dog owners,  veterinary  surgeons  and  veterinary  nurses.  A qualitative  methodology  was
adopted,  using  semi-structured  interviews  and  focus  groups.  Thematic  analysis  of  these  data  identified
three  themes:  awareness  of  potential  risks;  recognition  of  adverse  events;  and  influence  of  risk perception
on the use  of  NSAIDs.  Awareness  of,  and concern  about,  the risk  of  adverse  events  associated  with  NSAID
administration  to dogs  with  osteoarthritis  was  high  in all  groups,  with  veterinary  surgeons  being one of a
variety  of information  sources  used  by owners  to  acquire  this  knowledge.  Veterinary  surgeons  described
difficulty  in  recognising,  managing  and  avoiding  adverse  events  associated  with  NSAIDs.  When  adverse
events  occurred,  a  wide  range  of  management  approaches  were  adopted  ranging  from  a brief  drug  respite
to permanent  cessation  of  administration  of  any NSAIDs  to that dog.  Commonly  employed  approaches
to  minimise  risk  included  dose  reduction  and  screening  blood  tests.  This  study  describes  a high  level of
concern  about  the risks  associated  with  long  term  NSAID  administration  to dogs  with  osteoarthritis  and
highlights  a diverse  range  of  strategies  employed  to minimise  these  risks.  The  evidence  base  for  these
strategies  is  poor,  and  this  may present  a risk  to animal  welfare  if  the  affected  dogs  are  not  receiving
adequate  analgesia.  In order  to  address  this,  more  accurate  and  comprehensive  data  must  be supplied  to
both veterinary  professionals  and  owners  on the  true frequency  of  adverse  events  associated  with  long
term administration  of veterinary  NSAIDs  and  how  best to  avoid  them.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly
sed to treat dogs with osteoarthritis (Sanderson et al., 2009). Sys-
ematic reviews have assessed the efficacy (Aragon et al., 2007;
anderson et al., 2009) and safety of veterinary NSAIDs (Innes et al.,
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167-5877/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
2010; Monteiro-Steagall et al., 2013). However, studies reporting
long term safety are lacking (Innes et al., 2010), and reporting of
adverse events may be incomplete, both in clinical trials and passive
surveillance (Hunt et al., 2015). Concern about adverse events asso-
ciated with the administration of NSAIDs to small animals remains
a barrier to their prescription by veterinary surgeons (Bell et al.,
2014). The attitudes of pet owners regarding NSAID safety have not
previously been reported in peer reviewed literature, but survey
data has found a link between safety concerns and poor compli-
ance (Zoetis Inc., 2013). This may  have serious implications for the
welfare of animals not receiving prescribed analgesia.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The attitudes of patients (Carnes et al., 2008; Milder et al., 2011a;
aba et al., 2013) and healthcare professionals (Mikhail et al., 2007;
avazos et al., 2008; Braund and Abbott, 2011) to the use and safety
f NSAIDs for human osteoarthritis are well documented. Several
tudies have demonstrated an important role for doctors in educat-
ng patients about potential adverse events associated with NSAIDs
Mikhail et al., 2007; Schmitt et al., 2011). The prescribing practice
f healthcare professionals is directly influenced by their experi-
nces, leading to avoidance of treatments that have caused adverse
vents in their own patients (Gabbay and May, 2004; Cavazos et al.,
008). Conversely, patients reliant on NSAIDs for analgesia may
gnore the risks if they have not personally experienced an adverse
vent (Milder et al., 2011b), though perceived risks have been asso-
iated with the decision to discontinue NSAID treatment (Laba et al.,
013).
Qualitative research uses a range of approaches including inter-
iews and focus groups to explore motivations, attitudes and
pinions (Bryman, 2012). A qualitative approach is particularly use-
ul in areas where little previous research has been conducted and
esults can be used to inform subsequent quantitative studies (e.g.
iseman-Orr et al., 2004). Analysis of data derived by qualita-
ive research takes many forms. Thematic analysis (described by
raun and Clarke, 2006) is widely used in healthcare research due
o its flexible methodology. The process is slow and iterative with
ranscribed lines of text coded for their meaning, with codes then
ollated into larger themes. The reports generated do not feature
umbers but instead provide an analytic narrative which makes
n argument related to the research question. A growing body of
iterature derived from qualitative research exists in veterinary
edicine (e.g. Coyne et al., 2014; Horseman et al., 2014; Page-Jones
nd Abbey, 2015).
The aim of this study was to use a qualitative approach to
haracterise the attitudes of dog owners, veterinary surgeons and
eterinary nurses in England and Scotland towards the safety of
SAIDs used to treat osteoarthritis in dogs. The objective was to
erform in-depth qualitative interviews with dog owners and focus
roups with veterinary surgeons and veterinary nurses to capture
 wide range of experiences of using NSAIDs to treat dogs with
steoarthritis.
. Materials and methods
This work forms a part of a larger qualitative study exploring
he experiences of dog owners, veterinary surgeons and veterinary
urses in the United Kingdom managing dogs with osteoarthritis.
nly results relevant to the aims of this study will be reported. Data
ere collected using semi-structured interviews for dog owners
nd focus groups for veterinary professionals (veterinary surgeons
nd nurses). Ethical approval for the study was granted by the ethics
ommittee at the School of Veterinary Medicine and Science, Uni-
ersity of Nottingham. Reporting follows the COREQ checklist (Tong
t al., 2007).
.1. Owner interviews
Interviews were conducted between February and August 2014.
he inclusion criteria for interviewees were: a) ownership of a dog
urrently treated or managed for osteoarthritis affecting at least
ne limb due to any underlying aetiology; AND b) ownership of a
og at least five years of age at the time of the interview; AND c)
he owner(s) and dog must live in the United Kingdom. Recruit-
ent was based on a purposive sampling frame constructed by
he authors (available on request) containing both dog and owner
ariables to capture the widest possible range of experiences.y Medicine 131 (2016) 121–126
Most interviewees were recruited by placing posters in the wait-
ing rooms of a convenience sample of 10 veterinary practices in
England and Scotland. All practices had previously agreed to col-
laborate with the Centre for Evidence-based Veterinary Medicine,
University of Nottingham. Posters asked owners of older dogs with
osteoarthritis to contact the lead author by email or telephone to
share their experiences. Additional interviewees were recruited
by snowball sampling or through the authors’ networks. Owners
who expressed an interest in participation were sent information
about the purpose of the study including details of the interviewer’s
background as a veterinary surgeon and owner of a dog with
osteoarthritis. If they agreed to participate, an interview date was
then arranged by email or telephone. Incentives to participate were
not provided. Interviews were conducted in the owners’ homes
by one researcher (ZB) who had received training in qualitative
research from the Health Experiences Research Group, University
of Oxford. A semi-structured interview guide (available on request),
piloted before use, was used to explore owner experiences. Per-
tinent to this manuscript, interviewees were asked about their
experiences of treating their dog’s osteoarthritis, and any previ-
ous experience of osteoarthritis in humans or other species. Where
owners had more than one dog with osteoarthritis, they chose
either to focus on one dog or described their experiences with more
than one dog. Interviews were conducted until data saturation was
reached (see below).
2.2. Veterinary focus groups
Focus groups were conducted between August and December
2014. The inclusion criterion was any practice from which owners
had been recruited; veterinary nurses and veterinary surgeons that
performed consultations with owners of dogs with osteoarthritis
within that practice were then invited to participate. A purposive
sampling frame ensured inclusion of a range of practice sizes, loca-
tions and types. Meetings were arranged through contact with one
member of staff at the practice who then recruited others to par-
ticipate; attendance was voluntary. Details of the purpose of the
study were available in advance. Food was  provided as an incen-
tive to attend meetings and to ease discussion (Braun and Clarke,
2013). Focus groups were conducted on the practice premises for
convenience and to provide a safe setting for open discussion. The
focus group for veterinary nurses was  conducted at a different
time to that of the veterinary surgeons within the same practice
to ensure both groups were comfortable to describe their experi-
ences. All focus groups were conducted by one researcher (ZB). A
semi-structured question list was used to prompt the participants
but where possible discussion was  allowed to proceed with mini-
mal  interruption. Questions focused on the diagnosis and treatment
of osteoarthritis in dogs.
2.3. Thematic analysis
Contextual field notes were made during the interviews and
focus groups. Interviews and focus groups were audio recorded and
professionally transcribed verbatim. Transcripts were not returned
to the participants. Transcribed interviews and focus groups were
read and reviewed several times by the lead author. Thematic anal-
ysis was performed following the six step plan described by Braun
and Clarke (2006) using the organisational support of nVivo (nVivo
v10, QSR). Constant comparison was  used to ensure all opinions
were included (Braun and Clarke, 2006; Coyne et al., 2014). The-
matic analysis was performed in tandem with data collection. Data
saturation for interviews and focus groups was  defined as the point
at which no additional themes emerged as a result of analysing new
transcripts; at this point recruitment for further participants was
halted. For the purpose of this secondary analysis, all extracts from
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oth interviews and focus groups that described use of NSAIDs were
crutinised, and coded into anticipated and emergent themes, as
escribed by Ziebland et al. (2004). Statistical analysis was  not per-
ormed as the qualitative purposive sampling methodology aimed
o capture a wide range of experiences rather than to represent a
opulation (Ziebland et al., 2004; Silverman, 2013).
. Results
Forty-nine owners expressed interest in the study. Seven-
een were either ineligible to participate, declined participation
hen provided with study details or did not have the time to be
nterviewed during the study period. Thirty-two interviews were
onducted, capturing the views of 40 owners about 35 dogs with
steoarthritis treated at seventeen different veterinary practices.
nterviews ranged from 52 to 170 min  in length. All dogs dis-
ussed by owners had received at least one of five different NSAIDs
carprofen, cimicoxib, firocoxib, meloxicam, robenacoxib) for their
steoarthritis. Five focus groups, each of approximately 60 min
ength, were run in four veterinary practices totalling 31 partici-
ants. Four focus groups were conducted with veterinary surgeons.
 single focus group was conducted with veterinary nurses in the
nly practice providing nurse clinics for dogs with osteoarthritis.
hematic analysis of the coded excerpts relating the use of NSAIDs
dentified three themes: awareness of potential risks; recognition
f adverse events; and the influence of risk perception on the use
f NSAIDs. Due to the word limits of this publication, exemplary
uotations are provided to illustrate each theme.
.1. Awareness of potential risks
Almost all owners were aware of one or more “side effects”
ssociated with the use of NSAIDs in dogs. Many drew analogies
etween NSAIDs used in humans and those prescribed for their
og. Rarely, owners had personal experience of adverse events due
o NSAIDs in people such as stomach ulceration. A few owners had
een told about adverse events associated with NSAID affecting the
ogs of friends or colleagues, and a couple had experienced adverse
vents with previous dogs. Most frequently, owners expressed
oncern about NSAID administration causing “organ damage” and
ess often gastrointestinal injury including vomiting, diarrhoea and
lceration. Some owners identified specific organs such as the liver
r kidneys which could be harmed. Adverse events were thought
o be associated with both longevity of dosing and high drug doses.
Some owners recalled warnings provided by the veterinary
urgeon at the time of initial NSAID administration. Often these
ncluded a comparison with human NSAIDs, which may  have
ssumed that owners would have knowledge of their associated
dverse events, and advice to give the medication with food to
void stomach ulcers. Very rarely, owners recalled being provided
ith printed information. A few owners asked the veterinary sur-
eon about the potential harms if no details were given. Drug data
heets were used as a source of information by a couple of owners;
thers remarked that the data sheet was not always available. One
wner highlighted the importance of this:
Now, the vet didn’t tell me  this, but I always read the leaflet anyway,
and it said with this one [robenacoxib] that it’s better to wait at least
thirty minutes after food before you give the tablet. [Owner 5]
The internet was a source of information about NSAIDs for
any owners. Most described performing a search using Google
sing terms such as “dog arthritis” to look for information about
reatment options. A few performed a more focused search to
ook for information about adverse events associated with par-
icular prescription treatments. Their motivation in all cases wasy Medicine 131 (2016) 121–126 123
to seek information to supplement that provided by their veteri-
nary surgeon. Several owners described finding websites which
alarmed them, particularly regarding reports of deaths associated
with carprofen. A few described their shock that a veterinary sur-
geon would prescribe a drug associated with death, though many
were aware that they should not trust everything they read on the
internet:
The vets didn’t tell me anything about it, and I’m afraid I looked
it up on the internet, and found that Rimadyl does disagree with
a lot of dogs. There’s an awful lot of nasty stories out there about
poisoning and all the rest but fortunately I’m well aware of internet
world. [Owner 11]
A few owners described the newer generation NSAIDs as safer
based on fewer reports of adverse events on the internet; for exam-
ple, one owner who  was very concerned about carprofen thought
cimicoxib had no potential for harm. Several owners said they
would appreciate more guidance from their veterinary surgeon
about how to interpret what they read online or which sites to
trust. Many said they would always want to check what they read
on the internet with their veterinary surgeon. Surprisingly, a couple
of owners were unaware of any adverse events associated with the
drugs, emphasising the important role of the veterinary surgeon in
educating owners:
No, I’m not aware of any side effects [associated with carprofen]. I
think if there were side effects [my vets] would tell me  so I tend not
to Google dogs. [Owner 30]
All veterinary professionals were aware of the potential for
adverse events with NSAIDs; concerns about hepatic and renal
compromise and gastrointestinal ulceration were commonly men-
tioned. Many veterinary surgeons discussed the safety advice they
gave to owners; typically, this matched what the owners described.
Most veterinary surgeons and veterinary nurses commented that
time pressure in the osteoarthritis consultation was a barrier to
a longer discussion. This was compounded by many diagnoses of
osteoarthritis being made during a consultation for another prob-
lem. Some veterinary professionals thought most of their owners
were aware of the risks associated with NSAID administration,
whilst others were less sure:
I don’t think many of them know in advance. . . . I don’t think in real-
ity before you start them on these things, I don’t think many clients
have much of an inkling as to the potential side effects [Veterinary
surgeon 1, Focus Group 2]
I think a lot of owners are aware that, particularly the well-known
Metacam, a lot of people are aware that it can be detrimental to
the health. [Veterinary nurse 3, Focus Group 4]
3.2. Recognition of adverse events
Some owners reported that their dog had experienced one
or more episodes of gastroenteritis whilst receiving an NSAID.
Typically this involved vomiting with or without blood, and/or
diarrhoea containing fresh blood or melena. Often, gastroenteritis
occurred soon after treatment inception but some dogs experi-
enced signs after prolonged NSAID dosing. Some dogs experienced
a single episode of vomiting or diarrhoea whilst others exhibited
clinical signs for longer.
[My vet] said ‘Let’s try Previcox.’ and then she was then having
problems with it, she was  bringing up frothy stuff, but it had little
streaks of blood in it. [Owner 15]
Owners reported that gastroprotectants such as ranitidine and
sucralfate were commonly prescribed after such episodes, and
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ometimes their use was long-term if NSAIDs were continued. Once
igns had abated, some dogs were re-introduced to the same NSAID
nd experienced no further adverse events, whilst others were
witched to a different NSAID or an alternative analgesic such as tra-
adol. This appeared to be determined by the individual approach
f the veterinary surgeon in charge of that case. Only a couple
f dogs experienced haematemesis on multiple different NSAIDs;
ost dogs appeared to tolerate a different NSAID much better.
She started on Previcox. And that gave her a bleed . . . Yeah, her
poos came all suddenly full of blood. I stopped it immediately, took
her back [to the vets], we gave her a break, and then changed her
to Rimadyl, and she’s been okay on that ever since. [Owner 16]
Other adverse events associated by owners with NSAIDs were
eported much less frequently. No owners reported renal or hepatic
ompromise as a result of the drugs, though one dog was  investi-
ated for hepatic side effects as a result of increasing liver enzymes
n routine biochemistry.
About three months later, because they’re monitoring her regularly,
[her liver values had] gone down again, then they went up again,
then they’d gone down again, so we’d decided that she’s just erratic.
But it was then the vet said “Oh dear, we’d better have a biopsy.”
and all the rest of it. Ooh! Panic! It was very expensive. . . I’m glad
we did it because we ruled out she hadn’t got cancer or anything.
But I still don’t know whether it was the Rimadyl that pushed them
up a bit. [Owner 7]
Veterinary professionals disagreed both within and between
ractices about the incidence of adverse events, with the veteri-
ary nurses perceiving the incidence to be highest. However, most
greed that adverse events were typically associated with post-
perative NSAID use rather than with dogs receiving NSAIDs for
steoarthritis.
I think it’s one of these where there is no real number. The clients say
to you, “What is the risk of vomiting and diarrhoea?” And normally
I say about one in 40. I don’t think it’s any less frequent than that
because I think it’s one of those things where probably each of us
will diagnose it, to some extent or another, at least once a week.
[Veterinary surgeon 1, Focus Group 1]
I think sometimes we’re attributing [gastrointestinal] signs to
the non-steroidals and they’re probably not purely caused by
non-steroidals. The number of animals that we see with [gastroin-
testinal] upsets, which look like non-steroidal side effects, where
they haven’t taken any, is probably bigger than the ones we see
that do. So, but obviously you have to err on the side of caution,
you have to assume it is the medication that could cause the side
effects. . ..  [Veterinary surgeon 3, Focus Group 2]
It was apparent that reporting of adverse events associated
ith NSAIDs to the Veterinary Medicine Directorate was extremely
ncommon, with difficultly recognising true adverse events being
ne reason for this. Many veterinary surgeons associated adverse
vents with poor owner compliance, citing examples of incorrect
osing, the drugs being given without food or continued admin-
stration to an ill dog as common causes. No veterinary surgeons
ould recall a case of severe hepatic or renal toxicity related to
SAIDs.
.3. Influence of risk perception on the use of NSAIDs
There was a clear impact on owners and veterinary profession-
ls of the awareness of potential adverse events related to NSAID
dministration. Many strategies were employed to minimise risks.
everal owners stated that their dog should or could not be treated
ith NSAIDs. Typically this was based on the dog having experi-y Medicine 131 (2016) 121–126
enced an adverse event whilst receiving an NSAID. Most veterinary
surgeons described their frustration at being unable to persuade
the owners of some dogs with osteoarthritis to ever use NSAID
treatments. A few owners held extremely strong beliefs about the
association between adverse events and specific NSAIDs.
I’m absolutely anti Rimadyl. It’s on my notes that never, ever give
my dogs Rimadyl. And then when I find they’ve had Rimadyl I
go mad. My parents’ cocker spaniel died of platelet eruption on
Rimadyl, at seven. . . It might be good pain relief but I will not have
it. [Owner 3]
Some veterinary surgeons elected to avoid NSAIDs in animals
they perceived to be at high risk of adverse events, typically due to
slight abnormalities on blood tests. The alternative treatment pre-
scribed was usually tramadol, though several veterinary surgeons
questioned its evidence base as an analgesic for canine chronic pain:
I don’t know what the studies are about what to commonly do,
but if anything I think as a practice we’re quite overly cautious I
think about [using NSAIDs] − which is a good thing. Sometimes I
think am I being overly cautious by starting on tramadol instead of
on Loxicom or something; I’m not too sure. [Veterinary surgeon 5,
Focus Group 1]
Several veterinary surgeons and owners described certain
NSAIDs as being “safer” than others; cimicoxib, firocoxib and robe-
nacoxib were typically mentioned in this context. A few veterinary
surgeons used one of these drugs as a first line for safety reasons,
whilst others switched if a dog experienced something believed to
be an adverse event. The subjective nature of these decisions was
frequently clear when examples were discussed:
. . . if [gastroenteritis] came on almost instantaneously, within days
of starting carprofen, and the animal was  really ill, then I would
be really ‘Maybe we can‘t really use non-steroidals with this.’ But
if on the other hand it came on after a few weeks, and it wasn’t
particularly bad, then yeah, take it off the carprofen for a while,
give it a wash-out period, get his tummy back to being normal
and then try on Previcox or Cimalgex. [Veterinary surgeon 1, Focus
Group 2]
Many owners and veterinary surgeons described their desire
to reduce the dose of NSAIDs. Some owners asked their veteri-
nary surgeon to reduce the dose and many veterinary surgeons
routinely lowered the daily dose over time. Veterinary surgeons
often expressed concern about owners taking NSAID dose reduc-
tion decisions into their own hands. This was  in sharp contrast to
their attitude to other treatments such as tramadol and supple-
ments where veterinary surgeons were typically happy for owners
to modify the dose. A less common strategy was to reduce dosing
frequency to alternate days. Most veterinary surgeons expressed
uncertainty about whether, when and how to reduce the dose;
within a practice there were frequently several methods. Many
acknowledged that they did not know how best to proceed but
most seemed confident that lower doses were effective.
A lot of them do seem fine. . .if  you’ve got a thirty-kilo dog, they
seem quite happy on a twenty-kilo dose. And the owners see all the
benefit from it. . . [Veterinary surgeon 2, Focus Group 5]
Some owners reported that their dogs underwent regular
screening blood tests whilst on NSAIDs; others could not recall their
dog ever having been tested. Blood tests were described by owners
as both providing comfort and as a source of major concern. One
owner, interviewed whilst waiting for blood test results, described
how her worry about adverse events had led to a blood test and her
subsequent concern about what the results might mean:
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I was  getting a bit twitchy. . . Because now he has Onsior forties
every day now. . ..  We  did a blood test on Thursday, we won’t get
the results back til Monday, to see how his insides are coping with
his meds. And if they’re compromised I’m not quite sure where we
go from there. [Owner 14]
Almost all veterinary surgeons reported that they performed
outine blood tests on dogs receiving NSAIDs. The frequency var-
ed widely within and between practices with some veterinary
urgeons insisting that dogs received a blood test before starting
reatment and others happy to wait several months before test-
ng. Most veterinary surgeons made decisions on the basis of basic
lood biochemistry; liver function assessment by bile acid stimula-
ion was not described. Several veterinary surgeons acknowledged
hat the results of blood tests rarely altered the dog’s treatment,
nd a few were unsure of how often tests should be performed:
Personally I think it’s the right thing to do the bloods, and I do do
the bloods, but whether or not we do it for the right reasons or
whether or not there’s much evidence that it’s actually necessary −
I think this is where there is a lack of knowledge around it. I totally
recommend people do do them and I do them longer term; but often
it’s not going to change what I do. More often it’s just a monitoring
thing. [Veterinary surgeon 2, Focus Group 1]
Veterinary surgeons recognised the need to balance quality
ith quantity of life when treating osteoarthritis, though several
avoured treatments they perceived to be safer over ones known to
e effective in older patients. Despite the risks, most owners con-
inued to give their dog an NSAID, albeit often at a low dose. Many
wners described the challenges of trading off pain relief and hap-
iness with the risk of side effects. Opinions varied on striking the
ight balance:
So as far as I’m concerned, if he’s comfortable I’d rather him be
comfortable, and die of liver failure at the age of ten than be in pain
but live ‘til twelve.  [Owner 20]
It would be nice to have eventually painkillers that would not have
any side effects. . . . That would be fantastic, rather than always
think ‘Yeah, well, put up with being a bit stiff because I’m worried
about painkillers’ [Owner 16]
. Discussion
This qualitative analysis of data derived by interviews with dog
wners and focus groups with veterinary professionals demon-
trates high awareness and concern about potential adverse events
ssociated with veterinary NSAIDs. This study demonstrates the
otential this concern has to affect both prescription of NSAIDs
y veterinary surgeons and compliance by owners. It highlights
everal major issues. Owners not satisfied with the information
rovided by their veterinary surgeon seek additional guidance, but
rustworthy sources are difficult to find. Veterinary surgeons are
nsure of the true incidence of adverse events associated with
SAIDs because they are hard to differentiate from concurrent dis-
ase. Veterinary surgeons are aware of little evidence to support
heir decisions to reduce the dose of NSAIDs or to perform regular
outine blood tests.
Some owners did not recollect a warning from their veteri-
ary surgeon about the potential for adverse events associated
ith NSAIDs, and others did not think the information provided
as adequate. Based on the focus groups data, it is likely that
any veterinary surgeons do warn owners about at least some ofhe potential adverse events, though many commented on signif-
cant time pressures in the consulting room. Concerns about the
ength (Everitt et al., 2013; Robinson et al., 2014) and complexity
Robinson et al., 2015) of veterinary consultations have previouslyy Medicine 131 (2016) 121–126 125
been raised and are likely to contribute to owners being unable
to recall important information. Similar concerns have been raised
by doctors prescribing NSAIDs (Mikhail et al., 2007). Many own-
ers turned to the internet to supplement their knowledge. Most
who did this recalled using broad search terms which brought up
many websites. Little research has been conducted into the use of
the internet by pet owners (Kogan et al., 2008) though veterinary
surgeons in the United Kingdom believe it to be widespread and
detrimental to pet health (British Veterinary Association, 2014).
This study confirms the conclusions of Kogan et al. (2008) that
owners would prefer to receive information from their veterinary
surgeon and would like more advice on which websites to trust.
Many owners of dogs with osteoarthritis expressed concern
about the safety of NSAIDs and some preferred to risk efficacy
by under-dosing their dog rather than risk adverse events. This
is in contrast to the use of NSAIDs in adult human patients with
osteoarthritis where qualitative research typically finds patients
are unaware of or do not consider the risks (Milder et al., 2011a;
Milder et al., 2011b; Schmitt et al., 2011). The decision making
role of dog owners is similar to that of parents of young children.
Research into attitudes surrounding the risks of childhood vacci-
nation (Wroe et al., 2005) discovered that some parents viewed
harms that occurred as a result of a decision not to immunise to be
more acceptable than those associated with adverse drug events
from vaccination. It is probable that a similar phenomenon occurs
in dog owners. This is an area which warrants further research as
it has clear implications for compliance and animal welfare as dogs
in pain go untreated.
Hunt et al. (2015) report on the frequency of adverse events fol-
lowing NSAID administration reported to the Veterinary Medicines
Directorate. It found emesis was the most frequently reported
adverse event associated with oral NSAIDs in dogs. Renal and hep-
atic insufficiently was  reported at a low frequency. In our focus
groups, some veterinary surgeons linked uncertainty about the
incidence of adverse events to their cautious behaviour regard-
ing dosing and monitoring. This highlights the importance of the
publication and dissemination of accurate data reporting the inci-
dence of adverse events associated with veterinary medicines. Hunt
et al. (2015) recognised that the reported frequency of emesis does
not match that of clinical studies. One cause of under-reporting
identified in the current study was difficulty in determining the
significance of gastroenteritis in dogs receiving NSAIDSs. Clearer
guidance may be required on reporting of suspect adverse events
to the Veterinary Medicines Directorate.
Several veterinary surgeons commented on the poor evidence
base for reduced dosing or monitoring of NSAIDs. Little has been
published on either subject in veterinary medicine. A study by
Wernham et al. (2011) examined the efficacy of meloxicam in
dogs with osteoarthritis at a progressively reduced dose. Many
dogs dropped out of the study as their owners perceived analge-
sia was inadequate but the authors concluded that dose reduction
may  be effective for some individuals. Use of the lowest effec-
tive dose is in dogs advocated by some authors for safety reasons
(Lomas and Grauer, 2015) and is advised for doctors using NSAIDs
in humans with osteoarthritis (Zhang et al., 2008). More research is
urgently needed into the efficacy of low-dose NSAIDs in dogs with
naturally occurring osteoarthritis. Many veterinarians performed
regular blood tests on dogs receiving NSAIDs but specific guidance
on monitoring of hepatic and renal parameters are rarely provided
in companion animal NSAID datasheets (National Office for Animal
Health (NOAH), 2014). Given the low frequency of renal and hepa-
totoxicity (Hunt et al., 2015) and the potential costs and morbidity
associated with phlebotomy, a stronger evidence-base is required
to guide decision making around biochemical monitoring.
These results should not be interpreted as representative of the
opinions of all dog owners or veterinary professionals in the United
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ingdom as the aim was to report the widest possible breadth of
xperience. However, as this area has not previously been explored
sing qualitative research, we highlight important issues and pro-
ide a foundation for future studies. It is possible that the method of
wner recruitment introduced respondent bias in selecting own-
rs who were highly committed to their dogs, but the range of
nterviewees and attitudes obtained was very broad. A failsafe
ormula does not exist to identify data saturation (Ziebland and
cPherson, 2006) and there is always a risk that additional partic-
pants could have articulated previously unrepresented attitudes.
owever, additional themes did not emerge in either the final focus
roup or the last four interviews so it is likely that data satura-
ion had occurred within the population available for inclusion.
he inclusion criteria excluded owners whose dogs were untreated.
xploring the attitudes of those owners was outside the scope of
his work but would be valuable future research. As with all qualita-
ive research, analysis by others may  have led to alternative themes.
oding was not replicated, as advocated by Morse (1997).
The findings of this study should be of value to anyone interested
n improving analgesia in dogs with osteoarthritis. The significant
arriers to compliance identified could be overcome by provision
f more accurate and comprehensive data to both veterinary pro-
essionals and owners on the true frequency of adverse events
ssociated with veterinary NSAIDs and how best to avoid them.
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